BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Garcia-Tsao G, Lim JK; Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802-1829. [PMID: 19455106 DOI: 10.1038/ajg.2009.191] [Cited by in Crossref: 168] [Cited by in F6Publishing: 146] [Article Influence: 12.9] [Reference Citation Analysis]
Number Citing Articles
1 Enomoto H, Sakai Y, Aizawa N, Iwata Y, Tanaka H, Ikeda N, Hasegawa K, Yoh K, Ishii A, Takashima T, Iwata K, Saito M, Imanishi H, Iijima H, Nishiguchi S. Association of amino acid imbalance with the severity of liver fibrosis and esophageal varices. Annals of Hepatology 2013;12:471-8. [DOI: 10.1016/s1665-2681(19)31011-7] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
2 Arroyo V, García-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61:396-407. [PMID: 24751830 DOI: 10.1016/j.jhep.2014.04.012] [Cited by in Crossref: 193] [Cited by in F6Publishing: 181] [Article Influence: 24.1] [Reference Citation Analysis]
3 Neff GW, Kemmer N, Duncan C, Alsina A. Update on the management of cirrhosis - focus on cost-effective preventative strategies. Clinicoecon Outcomes Res 2013;5:143-52. [PMID: 23626470 DOI: 10.2147/CEOR.S30675] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
4 Tseng Y, Ma L, Luo T, Zeng X, Li F, Li N, Wei Y, Chen S. Patient Response to Endoscopic Therapy for Gastroesophageal Varices Based on Endoscopic Ultrasound Findings. Gut Liver 2018;12:562-70. [PMID: 29699062 DOI: 10.5009/gnl17471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Solà E, Lens S, Guevara M, Martín-Llahí M, Fagundes C, Pereira G, Pavesi M, Fernández J, González-Abraldes J, Escorsell A. Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Hepatology. 2010;52:1783-1790. [PMID: 20931555 DOI: 10.1002/hep.23893] [Cited by in Crossref: 63] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
6 Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, Saeian K, Hafeezullah M, Bell DE, Sterling RK, Stravitz RT, Luketic V, White MB, Sanyal AJ. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138:2332-2340. [PMID: 20178797 DOI: 10.1053/j.gastro.2010.02.015] [Cited by in Crossref: 197] [Cited by in F6Publishing: 161] [Article Influence: 16.4] [Reference Citation Analysis]
7 Jaurigue MM, Cappell MS. Therapy for alcoholic liver disease. World J Gastroenterol 2014; 20(9): 2143-2158 [PMID: 24605013 DOI: 10.3748/wjg.v20.i9.2143] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
8 Hope AA, Morrison RS. Integrating Palliative Care with Chronic Liver Disease Care. J Palliat Care 2011;27:20-7. [DOI: 10.1177/082585971102700105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
9 Rodriguez E, Henrique Pereira G, Solà E, Elia C, Barreto R, Pose E, Colmenero J, Fernandez J, Navasa M, Arroyo V. Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes. Liver Transpl. 2015;21:1347-1354. [PMID: 26178066 DOI: 10.1002/lt.24210] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]
10 Garcia-Tsao G, Surawicz CM. Editorial: Clostridium difficile infection: Yet another predictor of poor outcome in cirrhosis. Am J Gastroenterol. 2010;105:114-116. [PMID: 20054307 DOI: 10.1038/ajg.2009.604] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hu X, Shang G, Zhang J, Chen Z, Fu L, Li J, Lu X. Clinical Yi-guan decoction for liver cirrhosis: A protocol for systematic review and meta analysis. Medicine (Baltimore) 2021;100:e24530. [PMID: 33787570 DOI: 10.1097/MD.0000000000024530] [Reference Citation Analysis]
12 Moctezuma-Velázquez C, García-Juárez I, Soto-Solís R, Hernández-Cortés J, Torre A. Nutritional assessment and treatment of patients with liver cirrhosis. Nutrition. 2013;29:1279-1285. [PMID: 23867207 DOI: 10.1016/j.nut.2013.03.017] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
13 Ishigami M, Onishi Y, Kamei H, Kiuchi T, Katano Y, Itoh A, Hirooka Y, Goto H. Impact of recipient age and preoperative fasting blood glucose level as the risk factors of living donor liver transplantation in cirrhotic patients in the recent comprehensive era with knowledge of indications: Recent status in a Japanese single center. Hepatol Res. 2013;43:1148-1155. [PMID: 23413786 DOI: 10.1111/hepr.12067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
14 Peñaloza-posada MA, Pérez-torres E, Pérez-hernández JL, Higuera-de la Tijera F. Non-invasive parameters as predictors of high risk of variceal bleeding in cirrhotic patients. Revista Médica Del Hospital General De México 2014;77:179-84. [DOI: 10.1016/j.hgmx.2014.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Elia C, Graupera I, Barreto R, Solà E, Moreira R, Huelin P, Ariza X, Solé C, Pose E, Baiges A, Fabrellas N, Poch E, Fernández J, Arroyo V, Ginès P. Severe acute kidney injury associated with non-steroidal anti-inflammatory drugs in cirrhosis: A case-control study. Journal of Hepatology 2015;63:593-600. [DOI: 10.1016/j.jhep.2015.04.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
16 Qi X, Han G, He C, Yin Z, Zhang H, Wang J, Xia J, Cai H, Yang Z, Bai M, Wu K, Fan D. Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: a hypothesis. Med Sci Monit 2012;18:HY37-41. [PMID: 22847208 DOI: 10.12659/msm.883252] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
17 Smith MM. Emergency: Variceal hemorrhage from esophageal varices associated with alcoholic liver disease. Am J Nurs 2010;110:32-9; quiz 40-1. [PMID: 20107398 DOI: 10.1097/01.NAJ.0000368049.57482.00] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Takaki A, Maeshima Y, Yagi T, Katayama A, Hinamoto N, Akagi S, Sugiyama H, Tomoda T, Iwasaki Y, Yasunaka T, Ikeda F, Miyake Y, Kobashi H, Hirano A, Makino H, Yamamoto K. Peritoneovenous shunting for refractory ascites results in worsening of nephrotic syndrome. Hepatol Res 2012;42:1048-53. [PMID: 22998724 DOI: 10.1111/j.1872-034X.2012.01012.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Flamm SL, Mullen KD, Heimanson Z, Sanyal AJ. Rifaximin has the potential to prevent complications of cirrhosis. Therap Adv Gastroenterol. 2018;11:1756284818800307. [PMID: 30283499 DOI: 10.1177/1756284818800307] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
20 Horsley-Silva JL, Vargas HE. Gastrointestinal endoscopy in the cirrhotic patient. Expert Rev Gastroenterol Hepatol. 2015;9:1005-1013. [PMID: 25967459 DOI: 10.1586/17474124.2015.1044978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
21 Solà E, Ginès P. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives. J Hepatol 2010;53:1135-45. [PMID: 20850887 DOI: 10.1016/j.jhep.2010.08.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 55] [Article Influence: 5.9] [Reference Citation Analysis]
22 Asrani SK, Larson JJ, Yawn B, Therneau TM, Kim WR. Underestimation of liver-related mortality in the United States. Gastroenterology. 2013;145:375-382.e1-2. [PMID: 23583430 DOI: 10.1053/j.gastro.2013.04.005] [Cited by in Crossref: 172] [Cited by in F6Publishing: 161] [Article Influence: 19.1] [Reference Citation Analysis]
23 Ertel AE, Chang AL, Kim Y, Shah SA. Management of gastrointestinal bleeding in patients with cirrhosis. Curr Probl Surg 2016;53:366-95. [PMID: 27585818 DOI: 10.1067/j.cpsurg.2016.06.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Buonomo B, Lacitignola D. Modeling peer influence effects on the spread of high–risk alcohol consumption behavior. Ricerche mat 2014;63:101-17. [DOI: 10.1007/s11587-013-0167-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
25 Alessandria C, Elia C, Mezzabotta L, Risso A, Andrealli A, Spandre M, Morgando A, Marzano A, Rizzetto M. Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study. Dig Liver Dis. 2011;43:881-886. [PMID: 21741331 DOI: 10.1016/j.dld.2011.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
26 Yoo H, Lee JM, Yoon JH, Kang HJ, Lee SM, Yang HK, Han JK. T2* Mapping from Multi-Echo Dixon Sequence on Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Hepatic Fat Quantification: Can It Be Used for Hepatic Function Assessment? Korean J Radiol. 2017;18:682-690. [PMID: 28670163 DOI: 10.3348/kjr.2017.18.4.682] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
27 Enomoto H, Inoue S, Matsuhisa A, Nishiguchi S. Diagnosis of spontaneous bacterial peritonitis and an in situ hybridization approach to detect an "unidentified" pathogen. Int J Hepatol. 2014;2014:634617. [PMID: 25132996 DOI: 10.1155/2014/] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Khan A, Ayub M, Khan WM. Hyperammonemia Is Associated with Increasing Severity of Both Liver Cirrhosis and Hepatic Encephalopathy. Int J Hepatol 2016;2016:6741754. [PMID: 27847646 DOI: 10.1155/2016/6741754] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
29 Lannerstedt H, Konopski Z, Sandvik L, Haaland T, Løberg EM, Haukeland JW. Combining transient elastography with FIB4 enhances sensitivity in detecting advanced fibrosis of the liver. Scand J Gastroenterol. 2013;48:93-100. [PMID: 23205894 DOI: 10.3109/00365521.2012.746389] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
30 Louie KS, St Laurent S, Forssen UM, Mundy LM, Pimenta JM. The high comorbidity burden of the hepatitis C virus infected population in the United States. BMC Infect Dis 2012;12:86. [PMID: 22494445 DOI: 10.1186/1471-2334-12-86] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 5.6] [Reference Citation Analysis]
31 Tandon P, Garcia-Tsao G. Renal dysfunction is the most important independent predictor of mortality in cirrhotic patients with spontaneous bacterial peritonitis. Clin Gastroenterol Hepatol. 2011;9:260-265. [PMID: 21145427 DOI: 10.1016/j.cgh.2010.11.038] [Cited by in Crossref: 105] [Cited by in F6Publishing: 92] [Article Influence: 8.8] [Reference Citation Analysis]
32 Enomoto H, Inoue S, Matsuhisa A, Aizawa N, Imanishi H, Saito M, Iwata Y, Tanaka H, Ikeda N, Sakai Y, Takashima T, Shimomura S, Iijima H, Nakamura H, Nishiguchi S. Development of a new in situ hybridization method for the detection of global bacterial DNA to provide early evidence of a bacterial infection in spontaneous bacterial peritonitis. Journal of Hepatology 2012;56:85-94. [DOI: 10.1016/j.jhep.2011.06.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
33 Allegretti AS, Ortiz G, Kalim S, Wibecan J, Zhang D, Shan HY, Xu D, Chung RT, Karumanchi SA, Thadhani RI. Siglec-7 as a Novel Biomarker to Predict Mortality in Decompensated Cirrhosis and Acute Kidney Injury. Dig Dis Sci 2016;61:3609-20. [PMID: 27655105 DOI: 10.1007/s10620-016-4316-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
34 Elyamany AS, Salem PE. Assessment of splenic stiffness using elastography for prediction of varices in HCV-related hepatic cirrhosis: . Egyptian Liver Journal 2014;4:36-40. [DOI: 10.1097/01.elx.0000445718.72019.e8] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
35 Qi XS, Bai M, Fan DM. Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis. World J Gastroenterol 2014; 20(32): 11463-11466 [PMID: 25170238 DOI: 10.3748/wjg.v20.i32.11463] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
36 Garcia-tsao G. Ascites. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 283-95. [DOI: 10.1016/b978-1-4377-0881-3.00018-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther. 2010;31:537-547. [PMID: 20002027 DOI: 10.1111/j.1365-2036.2009.04211.x] [Cited by in Crossref: 163] [Cited by in F6Publishing: 127] [Article Influence: 12.5] [Reference Citation Analysis]
38 Patel MV, Patel KB, Gupta S, Michalsen A, Stapelfeldt E, Kessler CS. A Complex Multiherbal Regimen Based on Ayurveda Medicine for the Management of Hepatic Cirrhosis Complicated by Ascites: Nonrandomized, Uncontrolled, Single Group, Open-Label Observational Clinical Study. Evid Based Complement Alternat Med 2015;2015:613182. [PMID: 26339267 DOI: 10.1155/2015/613182] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
39 Fox RK. Toward the Effective Co-management of Patients with Cirrhosis by Primary Care Providers and Specialists. Dig Dis Sci 2015;60:2576-8. [DOI: 10.1007/s10620-015-3704-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Baghy K, Iozzo RV, Kovalszky I. Decorin-TGFβ axis in hepatic fibrosis and cirrhosis. J Histochem Cytochem. 2012;60:262-268. [PMID: 22260996 DOI: 10.1369/0022155412438104] [Cited by in Crossref: 92] [Cited by in F6Publishing: 94] [Article Influence: 9.2] [Reference Citation Analysis]
41 von Trotha KT, Binnebösel M, Truong S, Behrendt FF, Wasmuth HE, Neumann UP, Jansen M. Severe gastric variceal haemorrhage due to splenic artery thrombosis and consecutive arterial bypass. BMC Surg 2011;11:14. [PMID: 21711534 DOI: 10.1186/1471-2482-11-14] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Abdu B, Akolkar S, Picking C, Boura J, Piper M. Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis. Dig Dis Sci 2021;66:4035-45. [PMID: 33274417 DOI: 10.1007/s10620-020-06750-0] [Reference Citation Analysis]
43 Ullah A, Chen G, Hussain A, Khan H, Abbas A, Zhou Z, Shafiq M, Ahmad S, Ali U, Usman M, Raza F, Ahmed A, Qiu Z, Zheng M, Liu D. Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis. Int J Nanomedicine 2021;16:4451-70. [PMID: 34234436 DOI: 10.2147/IJN.S314367] [Reference Citation Analysis]
44 Enomoto H, Inoue S, Matsuhisa A, Nishiguchi S. Diagnosis of spontaneous bacterial peritonitis and an in situ hybridization approach to detect an "unidentified" pathogen. Int J Hepatol. 2014;2014:634617. [PMID: 25132996 DOI: 10.1155/2014/] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
45 Rao H, Wei L, Li H, Yang R, Zhang H, Shang J, Chen H, Li J, Xie Q, Gao Z, Wang L, Wei J, Jiang J, Sun Y; CCgenos Study Group. Prevalence of abnormal glycometabolism in treatment-naive patients with hepatitis C virus infection in a Chinese Han population. J Gastroenterol Hepatol 2015;30:1049-56. [PMID: 25611567 DOI: 10.1111/jgh.12901] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
46 Dekkers IA, Lamb HJ. Clinical application and technical considerations of T1 & T2(*) mapping in cardiac, liver, and renal imaging. Br J Radiol 2018;91:20170825. [PMID: 29975154 DOI: 10.1259/bjr.20170825] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
47 Liu C, Sun Y, Yang Y, Feng Y, Xie X, Qi L, Liu K, Wang X, Zhu Q, Zhao X. Gadobenate dimeglumine-enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosis. Eur Radiol 2021;31:5840-50. [PMID: 33533990 DOI: 10.1007/s00330-021-07702-6] [Reference Citation Analysis]
48 Theodorakopoulos T, Kalafateli M, Kalambokis GN, Samonakis DN, Aggeletopoulou I, Tsolias C, Mantaka A, Tselekouni P, Vourli G, Assimakopoulos SF, Gogos C, Thomopoulos K, Milionis H, Triantos C. Natural history of grade 1 ascites in patients with liver cirrhosis. Ann Gastroenterol 2021;34:93-103. [PMID: 33414628 DOI: 10.20524/aog.2020.0553] [Reference Citation Analysis]
49 Mizuguchi T, Kawamoto M, Meguro M, Nakamura Y, Harada K, Kukita K, Hirata K. Prognostic impact of preoperative the branched-chain amino acid to the tyrosine ratio in hepatocellular carcinoma patients after initial hepatectomy. J Gastrointest Surg. 2011;15:1433-1439. [PMID: 21607795 DOI: 10.1007/s11605-011-1566-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
50 Kim JJ, Tsukamoto MM, Mathur AK, Ghomri YM, Hou LA, Sheibani S, Runyon BA. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol. 2014;109:1436-1442. [PMID: 25091061 DOI: 10.1038/ajg.2014.212] [Cited by in Crossref: 76] [Cited by in F6Publishing: 56] [Article Influence: 9.5] [Reference Citation Analysis]
51 Pijls KE, Smolinska A, Jonkers DM, Dallinga JW, Masclee AA, Koek GH, van Schooten FJ. A profile of volatile organic compounds in exhaled air as a potential non-invasive biomarker for liver cirrhosis. Sci Rep. 2016;6:19903. [PMID: 26822454 DOI: 10.1038/srep19903] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
52 Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World J Gastroenterol 2020; 26(40): 6111-6140 [PMID: 33177789 DOI: 10.3748/wjg.v26.i40.6111] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
53 Lin J, Wu JF, Zhang Q, Zhang HW, Cao GW. Virus-related liver cirrhosis: Molecular basis and therapeutic options. World J Gastroenterol 2014; 20(21): 6457-6469 [PMID: 24914367 DOI: 10.3748/wjg.v20.i21.6457] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
54 Bajaj JS, Ratliff SM, Heuman DM, Lapane KL. Non-selective beta-blockers are not associated with serious infections in veterans with cirrhosis. Aliment Pharmacol Ther. 2013;38:407-414. [PMID: 23786291 DOI: 10.1111/apt.12382] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
55 Sasidharan Nair GV, Mathen PG, Pillai MG, Gireesh Kumar KP, Velayudhan KK, Sreekrishnan TP. Initial choice of antibiotic in recurrent spontaneous bacterial peritonitis: A retrospective study. Int J Crit Illn Inj Sci 2019;9:187-90. [PMID: 31879606 DOI: 10.4103/IJCIIS.IJCIIS_49_18] [Reference Citation Analysis]
56 Poca M, Alvarado-Tapias E, Concepción M, Pérez-Cameo C, Cañete N, Gich I, Romero C, Casas M, Román E, Castells L, Vargas V, Carrión JA, Guarner C, Soriano G. Predictive model of mortality in patients with spontaneous bacterial peritonitis. Aliment Pharmacol Ther 2016;44:629-37. [PMID: 27464682 DOI: 10.1111/apt.13745] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
57 Kang SH, Lee YB, Lee JH, Nam JY, Chang Y, Cho H, Yoo JJ, Cho YY, Cho EJ, Yu SJ, Kim MY, Kim YJ, Baik SK, Yoon JH. Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy. Aliment Pharmacol Ther. 2017;46:845-855. [PMID: 28836723 DOI: 10.1111/apt.14275] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
58 Enomoto H, Inoue SI, Matsuhisa A, Iwata Y, Aizawa N, Sakai Y, Takata R, Ikeda N, Hasegawa K, Nakano C, Nishimura T, Yoh K, Miyamoto Y, Ishii N, Yuri Y, Ishii A, Takashima T, Nishikawa H, Iijima H, Nishiguchi S. Amplification of bacterial genomic DNA from all ascitic fluids with a highly sensitive polymerase chain reaction. Mol Med Rep 2018;18:2117-23. [PMID: 29901148 DOI: 10.3892/mmr.2018.9159] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila FI, Soares-Weiser K, Uribe M. Antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding. Cochrane Database Syst Rev 2010;:CD002907. [PMID: 20824832 DOI: 10.1002/14651858.CD002907.pub2] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
60 Trifan A, Stoica O, Stanciu C, Cojocariu C, Singeap AM, Girleanu I, Miftode E. Clostridium difficile infection in patients with liver disease: a review. Eur J Clin Microbiol Infect Dis 2015;34:2313-24. [PMID: 26440041 DOI: 10.1007/s10096-015-2501-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
61 Lim TS, Kim BK, Lee JW, Lee YK, Chang S, Kim SU, Kim DY, Ahn SH, Han KH, Chon CY. Use of the delta neutrophil index as a prognostic factor of mortality in patients with spontaneous bacterial peritonitis: implications of a simple and useful marker. PLoS One. 2014;9:e86884. [PMID: 24466280 DOI: 10.1371/journal.pone.0086884] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
62 Cat TB, Liu-DeRyke X. Medical management of variceal hemorrhage. Crit Care Nurs Clin North Am. 2010;22:381-393. [PMID: 20691388 DOI: 10.1016/j.ccell.2010.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
63 Kikuchi N, Uojima H, Hidaka H, Iwasaki S, Wada N, Kubota K, Nakazawa T, Shibuya A, Fujikawa T, Kako M, Sato T, Koizumi W. Prospective study for an independent predictor of prognosis in liver cirrhosis based on the new sarcopenia criteria produced by the Japan Society of Hepatology. Hepatol Res 2021;51:968-78. [PMID: 34269502 DOI: 10.1111/hepr.13698] [Reference Citation Analysis]
64 Ishida J, Konishi M, Ebner N, Springer J. Repurposing of approved cardiovascular drugs. J Transl Med 2016;14:269. [PMID: 27646033 DOI: 10.1186/s12967-016-1031-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 6.3] [Reference Citation Analysis]
65 Timoh T, Protano MA, Wagman G, Bloom M, Vittorio TJ. A perspective on cirrhotic cardiomyopathy. Transplant Proc. 2011;43:1649-1653. [PMID: 21693251 DOI: 10.1016/j.transproceed.2011.01.188] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
66 Nasr P, Hilliges A, Thorelius L, Kechagias S, Ekstedt M. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2016;51:1126-32. [DOI: 10.3109/00365521.2016.1172336] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
67 Torgersen J, Kallan MJ, Carbonari DM, Park LS, Mehta RL, D'Addeo K, Tate JP, Lim JK, Goetz MB, Rodriguez-Barradas MC, Bräu N, Brown ST, Taddei TH, Justice AC, Lo Re V 3rd. Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma. J Acquir Immune Defic Syndr 2020;85:530-4. [PMID: 33185999 DOI: 10.1097/QAI.0000000000002510] [Reference Citation Analysis]
68 Fowler KJ, Saad NE, Linehan D. Imaging Approach to Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colorectal Cancer. Surgical Oncology Clinics of North America 2015;24:19-40. [DOI: 10.1016/j.soc.2014.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
69 Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, Ridola L, Attili AF, Venditti M. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol. 2010;8:979-985. [PMID: 20621200 DOI: 10.1016/j.cgh.2010.06.024] [Cited by in Crossref: 198] [Cited by in F6Publishing: 182] [Article Influence: 16.5] [Reference Citation Analysis]
70 Park WG, Shaheen NJ, Cohen J, Pike IM, Adler DG, Inadomi JM, Laine LA, Lieb JG 2nd, Rizk MK, Sawhney MS, Wani S. Quality indicators for EGD. Am J Gastroenterol 2015;110:60-71. [PMID: 25448872 DOI: 10.1038/ajg.2014.384] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
71 Qi X, Han G, Wu K, Fan D. A Confusing Relationship Between Child–Turcotte–Pugh Class A and Compensated Cirrhosis. American Journal of Gastroenterology 2010;105:470-2. [DOI: 10.1038/ajg.2009.626] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
72 Gaetano JN, Micic D, Aronsohn A, Reddy G, Te H, Reau NS, Jensen D. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites: The benefit of paracentesis. Journal of Gastroenterology and Hepatology 2016;31:1025-30. [DOI: 10.1111/jgh.13255] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
73 Tocia C, Dumitru A, Alexandrescu L, Popescu R, Dumitru E. Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis. World J Hepatol 2020; 12(12): 1267-1275 [PMID: 33442453 DOI: 10.4254/wjh.v12.i12.1267] [Reference Citation Analysis]
74 Singal AK, Shah VH. Alcoholic hepatitis: prognostic models and treatment. Gastroenterol Clin North Am. 2011;40:611-639. [PMID: 21893277 DOI: 10.1016/j.gtc.2011.06.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
75 Annicchiarico BE, Riccioni ME, Siciliano M, Urgesi R, Spada C, Caracciolo G, Gasbarrini A, Costamagna G. A pilot study of capsule endoscopy after a standard meal for the detection and grading of oesophageal varices in cirrhotic patients. Dig Liver Dis. 2014;46:997-1000. [PMID: 25192604 DOI: 10.1016/j.dld.2014.08.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
76 Mukerji AN, Patel V, Jain A. Improving survival in decompensated cirrhosis. Int J Hepatol. 2012;2012:318627. [PMID: 22811919 DOI: 10.1155/2012/318627] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
77 Thévenot T, Briot C, Macé V, Lison H, Elkrief L, Heurgué-Berlot A, Bureau C, Jézéquel C, Riachi G, Louvet A, Pauwels A, Ollivier-Hourmand I, Anty R, Carbonell N, Labadie H, Aziz K, Grasset D, Nguyen-Khac E, Kaassis M, Hermann S, Tanné F, Mouillot T, Roux O, Le Thuaut A, Cervoni JP, Cadranel JF, Schnee M; CFEHTP, ANGH and the PerDRISLA study group. The Periscreen Strip Is Highly Efficient for the Exclusion of Spontaneous Bacterial Peritonitis in Cirrhotic Outpatients. Am J Gastroenterol 2016;111:1402-9. [PMID: 27619833 DOI: 10.1038/ajg.2016.344] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
78 Ho SB, Matheny ME, Schnabl BE. Changes in Hospital Admissions and Mortality for Complications of Cirrhosis: Implications for Clinicians and Health Systems. Gut Liver 2016;10:8-9. [PMID: 26696026 DOI: 10.5009/gnl15593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
79 Tang B, Zhu J, Li J, Fan K, Gao Y, Cheng S, Kong C, Zheng L, Wu F, Weng Q, Lu C, Ji J. The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Commun Signal 2020;18:174. [PMID: 33115468 DOI: 10.1186/s12964-020-00663-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
80 Tseng Y, Ma L, Li S, Luo T, Luo J, Zhang W, Wang J, Chen S. Application of CT-based radiomics in predicting portal pressure and patient outcome in portal hypertension. Eur J Radiol 2020;126:108927. [PMID: 32146345 DOI: 10.1016/j.ejrad.2020.108927] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
81 Fukui H. How leaky gut and endotoxemia induce bacterial infection in cirrhosis and gastrointestinal hemorrhage? J Gastroenterol Hepatol. 2011;26:423-425. [PMID: 21332539 DOI: 10.1111/j.1440-1746.2011.06668.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
82 May D, Djonov V, Zamir G, Bala M, Safadi R, Sklair-Levy M, Keshet E. A transgenic model for conditional induction and rescue of portal hypertension reveals a role of VEGF-mediated regulation of sinusoidal fenestrations. PLoS One 2011;6:e21478. [PMID: 21779329 DOI: 10.1371/journal.pone.0021478] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
83 Yoon JH, Lee JM, Kim E, Okuaki T, Han JK. Quantitative Liver Function Analysis: Volumetric T1 Mapping with Fast Multisection B1 Inhomogeneity Correction in Hepatocyte-specific Contrast-enhanced Liver MR Imaging. Radiology 2017;282:408-17. [PMID: 27697007 DOI: 10.1148/radiol.2016152800] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
84 Gaglio PJ Jr, Gaglio PJ Sr. Complications in patients with alcohol-associated liver disease who undergo liver transplantation. Clin Liver Dis. 2012;16:865-875. [PMID: 23101987 DOI: 10.1016/j.cld.2012.08.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
85 Sanchez-jimenez B, Chavez-tapia NC, Jakobsen JC, Nikolova D, Gluud C; Cochrane Hepato-Biliary Group. Antibiotic prophylaxis for people with cirrhosis and variceal bleeding. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013214] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
86 Kim BG, Park NH, Lee SB, Lee H, Lee BU, Park JH, Jung SW, Jeong ID, Bang S, Shin JW. Mortality, liver transplantation and hepatic complications in patients with treatment-naïve chronic hepatitis B treated with entecavir vs tenofovir. J Viral Hepat 2018;25:1565-75. [DOI: 10.1111/jvh.12971] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 9.5] [Reference Citation Analysis]
87 Guevara M, Terra C, Nazar A, Solà E, Fernández J, Pavesi M, Arroyo V, Ginès P. Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study. J Hepatol. 2012;57:759-765. [PMID: 22732511 DOI: 10.1016/j.jhep.2012.06.013] [Cited by in Crossref: 119] [Cited by in F6Publishing: 91] [Article Influence: 11.9] [Reference Citation Analysis]
88 Tonan T, Fujimoto K, Qayyum A. Chronic hepatitis and cirrhosis on MR imaging. Magn Reson Imaging Clin N Am 2010;18:383-402, ix. [PMID: 21094446 DOI: 10.1016/j.mric.2010.08.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
89 Shigemi D, Nakanishi K, Miyazaki M, Shibata Y, Suzuki S. The Effect of the Gelatinous Lactulose for Postoperative Bowel Movement in the Patients Undergoing Cesarean Section. Int Sch Res Notices 2014;2014:752862. [PMID: 27433530 DOI: 10.1155/2014/752862] [Reference Citation Analysis]
90 Wallen MP, Hall A, Dias KA, Ramos JS, Keating SE, Woodward AJ, Skinner TL, Macdonald GA, Arena R, Coombes JS. Impact of beta-blockers on cardiopulmonary exercise testing in patients with advanced liver disease. Aliment Pharmacol Ther 2017;46:741-7. [PMID: 28805258 DOI: 10.1111/apt.14265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
91 Ravaioli F, Montagnani M, Lisotti A, Festi D, Mazzella G, Azzaroli F. Noninvasive Assessment of Portal Hypertension in Advanced Chronic Liver Disease: An Update. Gastroenterol Res Pract 2018;2018:4202091. [PMID: 29977287 DOI: 10.1155/2018/4202091] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
92 Martín–llahí M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, Solá E, Pereira G, Marinelli M, Pavesi M, Fernández J, Rodés J, Arroyo V, Ginès P. Prognostic Importance of the Cause of Renal Failure in Patients With Cirrhosis. Gastroenterology 2011;140:488-496.e4. [DOI: 10.1053/j.gastro.2010.07.043] [Cited by in Crossref: 217] [Cited by in F6Publishing: 172] [Article Influence: 19.7] [Reference Citation Analysis]
93 Triantos C, Aggeletopoulou I, Kalafateli M, Spantidea PI, Vourli G, Diamantopoulou G, Tapratzi D, Michalaki M, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K. Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis. Sci Rep 2018;8:14065. [PMID: 30218108 DOI: 10.1038/s41598-018-32482-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
94 Triantos C, Kalafateli M, Aggeletopoulou I, Diamantopoulou G, Spantidea PI, Michalaki M, Vourli G, Konstantakis C, Assimakopoulos SF, Manolakopoulos S, Gogos C, Kyriazopoulou V, Mouzaki A, Thomopoulos K. Vitamin D-related immunomodulation in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2020;32:867-76. [PMID: 31789949 DOI: 10.1097/MEG.0000000000001597] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
95 Choi JH, Kim ER, Min BH, Choi D, Kang KJ, Lee JH, Rhee PL, Kim JJ, Rhee JC. The feasibility and safety of the endoscopic submucosal dissection of superficial gastric neoplastic lesions in patients with compensated liver cirrhosis: a retrospective study. Gut Liver. 2012;6:58-63. [PMID: 22375172 DOI: 10.5009/gnl.2012.6.1.58] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
96 Hickey R, Vouche M, Sze DY, Hohlastos E, Collins J, Schirmang T, Memon K, Ryu RK, Sato K, Chen R, Gupta R, Resnick S, Carr J, Chrisman HB, Nemcek AA Jr, Vogelzang RL, Lewandowski RJ, Salem R. Cancer concepts and principles: primer for the interventional oncologist-part II. J Vasc Interv Radiol 2013;24:1167-88. [PMID: 23810312 DOI: 10.1016/j.jvir.2013.04.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
97 Peng CY, Chien RN, Liaw YF. Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy. J Hepatol. 2012;57:442-450. [PMID: 22504333 DOI: 10.1016/j.jhep.2012.02.033] [Cited by in Crossref: 119] [Cited by in F6Publishing: 113] [Article Influence: 11.9] [Reference Citation Analysis]
98 Woo GA, O'Brien C. Long-term management of alcoholic liver disease. Clin Liver Dis 2012;16:763-81. [PMID: 23101981 DOI: 10.1016/j.cld.2012.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
99 White JA, Gray SH, Li P, Simpson HN, McGuire BM, Eckhoff DE, Abdel Aal AMK, Saddekni S, Dubay DA. Current guidelines for chemoembolization for hepatocellular carcinoma: Room for improvement? Hepatol Commun 2017;1:338-46. [PMID: 29404463 DOI: 10.1002/hep4.1046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
100 Ge PS, Runyon BA. The changing role of beta-blocker therapy in patients with cirrhosis. J Hepatol. 2014;60:643-653. [PMID: 24076364 DOI: 10.1016/j.jhep.2013.09.016] [Cited by in Crossref: 83] [Cited by in F6Publishing: 66] [Article Influence: 9.2] [Reference Citation Analysis]
101 Park WG, Shaheen NJ, Cohen J, Pike IM, Adler DG, Inadomi JM, Laine LA, Lieb JG 2nd, Rizk MK, Sawhney MS, Wani S. Quality indicators for EGD. Gastrointest Endosc 2015;81:17-30. [PMID: 25480101 DOI: 10.1016/j.gie.2014.07.057] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 6.9] [Reference Citation Analysis]
102 Sims OT, Whalen CC, Nackerud LG, Bride BE. Longitudinal effects of selective serotonin reuptake inhibitor therapy and cytokine-related depression on hepatitis C viral logs during antiviral therapy. J Clin Psychopharmacol 2014;34:80-4. [PMID: 24135839 DOI: 10.1097/JCP.0b013e3182a47397] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
103 Baghy K, Dezso K, László V, Fullár A, Péterfia B, Paku S, Nagy P, Schaff Z, Iozzo RV, Kovalszky I. Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice. Lab Invest. 2011;91:439-451. [PMID: 20956977 DOI: 10.1038/labinvest.2010.172] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 5.2] [Reference Citation Analysis]
104 Zamora Nava LE, Aguirre Valadez J, Chávez-Tapia NC, Torre A. Acute-on-chronic liver failure: a review. Ther Clin Risk Manag. 2014;10:295-303. [PMID: 24790454 DOI: 10.2147/tcrm.s59723] [Cited by in Crossref: 5] [Cited by in F6Publishing: 16] [Article Influence: 0.6] [Reference Citation Analysis]
105 Pfeiffenberger J, Weiss KH, Stremmel W. Wilson disease: symptomatic liver therapy. Handb Clin Neurol 2017;142:205-9. [PMID: 28433104 DOI: 10.1016/B978-0-444-63625-6.00017-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
106 Weil D, Heurgue‐berlot A, Monnet E, Chassagne S, Cervoni J, Feron T, Grandvallet C, Muel E, Bronowicki J, Thiefin G, Di Martino V, Bardonnet K, Thévenot T. Accuracy of calprotectin using the Quantum Blue Reader for the diagnosis of spontaneous bacterial peritonitis in liver cirrhosis. Hepatol Res 2019;49:72-81. [DOI: 10.1111/hepr.13239] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
107 Garcia-tsao G. Ascites. In: Dooley JS, Lok ASF, Burroughs AK, Heathcote EJ, editors. Sherlock's Diseases of the Liver and Biliary System. Oxford: Wiley-Blackwell; 2011. pp. 210-33. [DOI: 10.1002/9781444341294.ch10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
108 Jwa HY, Cho YK, Choi EK, Kim HU, Song HJ, Na SY, Boo SJ, Jeong SU, Kim BS, Lee BW, Song BC. Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis. Clin Mol Hepatol 2016;22:183-7. [PMID: 27044771 DOI: 10.3350/cmh.2016.22.1.183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
109 Cheng Y, Zhang G, Shen W, Huang L, Zhang L, Xie S, Zhang X, Liu B. Impact of previous episodes of hepatic encephalopathy on short-term brain function recovery after liver transplantation: a functional connectivity strength study. Metab Brain Dis 2018;33:237-49. [DOI: 10.1007/s11011-017-0155-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
110 Sinkala E, Kapulu MC, Besa E, Zyambo K, Chisoso NJ, Foster GR, Kelly P. Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis. Liver Int 2016;36:145-50. [PMID: 26058680 DOI: 10.1111/liv.12891] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
111 Moon AM, Dominitz JA, Ioannou GN, Lowy E, Beste LA. Use of Antibiotics Among Patients With Cirrhosis and Upper Gastrointestinal Bleeding Is Associated With Reduced Mortality. Clin Gastroenterol Hepatol 2016;14:1629-1637.e1. [PMID: 27311621 DOI: 10.1016/j.cgh.2016.05.040] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
112 Walling AM, Ahluwalia SC, Wenger NS, Booth M, Roth CP, Lorenz K, Kanwal F, Dy S, Asch SM; Palliative Care Cirrhosis Quality Expert Panel. Palliative Care Quality Indicators for Patients with End-Stage Liver Disease Due to Cirrhosis. Dig Dis Sci 2017;62:84-92. [PMID: 27804005 DOI: 10.1007/s10620-016-4339-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
113 Barone C, Koeberle D, Metselaar H, Parisi G, Sansonno D, Spinzi G. Multidisciplinary approach for HCC patients: hepatology for the oncologists. Ann Oncol. 2013;24 Suppl 2:ii15-ii23. [PMID: 23715939 DOI: 10.1093/annonc/mdt053] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
114 Suk KT, Baik SK, Yoon JH, Cheong JY, Paik YH, Lee CH, Kim YS, Lee JW, Kim DJ, Cho SW, Hwang SG, Sohn JH, Kim MY, Kim YB, Kim JG, Cho YK, Choi MS, Kim HJ, Lee HW, Kim SU, Kim JK, Choi JY, Jun DW, Tak WY, Lee BS, Jang BK, Chung WJ, Kim HS, Jang JY, Jeong SW, Kim SG, Kwon OS, Jung YK, Choe WH, Lee JS, Kim IH, Shim JJ, Cheon GJ, Bae SH, Seo YS, Choi DH, Jang SJ; Korean Association for the Study of the Liver. Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol. 2012;18:1-21. [PMID: 22511898 DOI: 10.3350/kjhep.2012.18.1.1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 87] [Article Influence: 9.4] [Reference Citation Analysis]
115 Chavez-Tapia NC, Barrientos-Gutierrez T, Tellez-Avila F, Soares-Weiser K, Mendez-Sanchez N, Gluud C, Uribe M. Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review. Aliment Pharmacol Ther. 2011;34:509-518. [PMID: 21707680 DOI: 10.1111/j.1365-2036.2011.04746.x] [Cited by in Crossref: 136] [Cited by in F6Publishing: 96] [Article Influence: 12.4] [Reference Citation Analysis]
116 Cabibbo G, Rolle E, De Giorgio M, Genco C, Pressiani T, Spada F, Sacco R. Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenib. Expert Rev Anticancer Ther. 2011;11:1807-1816. [PMID: 22049974 DOI: 10.1586/era.11.139] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
117 Dabos KJ, Parkinson JA, Sadler IH, Plevris JN, Hayes PC. 1H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy. World J Hepatol 2015; 7(12): 1701-1707 [PMID: 26140090 DOI: 10.4254/wjh.v7.i12.1701] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
118 Czaja AJ. Hepatocellular carcinoma and other malignancies in autoimmune hepatitis. Dig Dis Sci. 2013;58:1459-1476. [PMID: 23306849 DOI: 10.1007/s10620-012-2525-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
119 Saberifiroozi M. Improving Quality of Care in Patients with Liver Cirrhosis. Middle East J Dig Dis 2017;9:189-200. [PMID: 29255576 DOI: 10.15171/mejdd.2017.73] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
120 Garcia-tsao G. Cirrhosis and Its Sequelae. Goldman's Cecil Medicine. Elsevier; 2012. pp. 999-1007. [DOI: 10.1016/b978-1-4377-1604-7.00156-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
121 Shin JW, Jung SW, Lee SB, Lee BU, Park BR, Park EJ, Park NH. Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir. Am J Gastroenterol 2018;113:998-1008. [PMID: 29880971 DOI: 10.1038/s41395-018-0093-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
122 Bañares R, Catalina MV, Yepes I. [Early TIPS in the treatment of severe bleeding from esophageal varices. A giant step forward?]. Gastroenterol Hepatol 2010;33:691-3. [PMID: 21059477 DOI: 10.1016/j.gastrohep.2010.09.001] [Reference Citation Analysis]
123 Rodriguez Villalvazo Y, McDanel JS, Beste LA, Sanchez AJ, Vaughan-Sarrazin M, Katz DA. Effect of travel distance and rurality of residence on initial surveillance for hepatocellular carcinoma in VA primary care patient with cirrhosis. Health Serv Res 2020;55:103-12. [PMID: 31763691 DOI: 10.1111/1475-6773.13241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
124 Fox RK. When to Consider Liver Transplant During the Management of Chronic Liver Disease. Medical Clinics of North America 2014;98:153-68. [DOI: 10.1016/j.mcna.2013.09.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
125 Costa G, Cruz RJ Jr, Abu-Elmagd KM. Surgical shunt versus TIPS for treatment of variceal hemorrhage in the current era of liver and multivisceral transplantation. Surg Clin North Am 2010;90:891-905. [PMID: 20637955 DOI: 10.1016/j.suc.2010.04.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
126 Ríos E, Serón P, Lanas F, Bonfill X, Quigley EM, Alonso-Coello P. Evaluation of the quality of clinical practice guidelines for the management of esophageal or gastric variceal bleeding. Eur J Gastroenterol Hepatol. 2014;26:422-431. [PMID: 24535595 DOI: 10.1097/MEG.0000000000000033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
127 Sanchez-jimenez B, Chavez-tapia NC, Jakobsen JC, Nikolova D, Gluud C; Cochrane Hepato-Biliary Group. Antibiotic prophylaxis versus placebo or no intervention for people with cirrhosis and variceal bleeding. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013175] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
128 Enomoto H, Inoue S, Matsuhisa A, Nishiguchi S. Diagnosis of spontaneous bacterial peritonitis and an in situ hybridization approach to detect an "unidentified" pathogen. Int J Hepatol 2014;2014:634617. [PMID: 25132996 DOI: 10.1155/2014/634617] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
129 Enomoto H, Sakai Y, Iwata Y, Takata R, Aizawa N, Ikeda N, Hasegawa K, Nakano C, Nishimura T, Yoh K, Ishii A, Takashima T, Nishikawa H, Iijima H, Nishiguchi S. Development of risky varices in alcoholic cirrhosis with a well-maintained nutritional status. World J Hepatol 2015; 7(21): 2358-2362 [PMID: 26413226 DOI: 10.4254/wjh.v7.i21.2358] [Reference Citation Analysis]
130 Hsu CS, Kao JH. Management of hepatitis C patients with decompensated liver disease. Expert Rev Gastroenterol Hepatol 2016;10:679-88. [PMID: 26782619 DOI: 10.1586/17474124.2016.1143775] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
131 Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, Saeian K, Hafeezullah M, Bell DE, Sterling RK. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138:2332-2340. [PMID: 20178797 DOI: 10.1038/ajg.2011.490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
132 Dastgheib M, Dehpour AR, Heidari M, Moezi L. The effects of intra-dorsal hippocampus infusion of pregnenolone sulfate on memory function and hippocampal BDNF mRNA expression of biliary cirrhosis-induced memory impairment in rats. Neuroscience 2015;306:1-9. [PMID: 26272534 DOI: 10.1016/j.neuroscience.2015.08.018] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
133 El-Shabrawi MH, Kamal NM. Medical management of chronic liver diseases (CLD) in children (part II): focus on the complications of CLD, and CLD that require special considerations. Paediatr Drugs. 2011;13:371-383. [PMID: 21999650 DOI: 10.2165/11591620-000000000-00000] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
134 Mellinger JL, Volk ML. Multidisciplinary management of patients with cirrhosis: a need for care coordination. Clin Gastroenterol Hepatol. 2013;11:217-223. [PMID: 23142204 DOI: 10.1016/j.cgh.2012.10.040] [Cited by in Crossref: 67] [Cited by in F6Publishing: 52] [Article Influence: 6.7] [Reference Citation Analysis]
135 Taegtmeyer AB, Haschke M, Tchambaz L, Buylaert M, Tschöpl M, Beuers U, Drewe J, Krähenbühl S. A study of the relationship between serum bile acids and propranolol pharmacokinetics and pharmacodynamics in patients with liver cirrhosis and in healthy controls. PLoS One 2014;9:e97885. [PMID: 24906133 DOI: 10.1371/journal.pone.0097885] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
136 Winger J, Michelfelder A. Diagnostic Approach to the Patient with Jaundice. Primary Care: Clinics in Office Practice 2011;38:469-82. [DOI: 10.1016/j.pop.2011.05.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
137 Riley DE, Liu L, Cohen B, Robinson S, Groessl EJ, Ho SB. Characteristics and impact of methamphetamine use in patients with chronic hepatitis C. J Addict Med 2014;8:25-32. [PMID: 24343127 DOI: 10.1097/ADM.0000000000000001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
138 Kniese C, Diab K, Ghabril M, Bosslet G. Indwelling Pleural Catheters in Hepatic Hydrothorax: A Single-Center Series of Outcomes and Complications. Chest 2019;155:307-14. [PMID: 29990479 DOI: 10.1016/j.chest.2018.07.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
139 Giannitrapani L, Granà W, Licata A, Schiavone C, Montalto G, Soresi M. Nontumorous Portal Vein Thrombosis in Liver Cirrhosis: Possible Role of β-Blockers. Med Princ Pract 2018;27:466-71. [PMID: 30107378 DOI: 10.1159/000492893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
140 Novelli S, Morabito V, Ruberto F, Bini F, Marinozzi F, Pugliese F, Berloco P, Pretagostini R. Diagnostic Value of Presepsin for Bacterial Infection in Cirrhosis: A Pilot Study. Transplant Proc 2020;52:1593-600. [PMID: 32305204 DOI: 10.1016/j.transproceed.2020.02.042] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Su TH, Hu TH, Chen CY, Huang YH, Chuang WL, Lin CC, Wang CC, Su WW, Chen MY, Peng CY, Chien RN, Huang YW, Wang HY, Lin CL, Yang SS, Chen TM, Mo LR, Hsu SJ, Tseng KC, Hsieh TY, Suk FM, Hu CT, Bair MJ, Liang CC, Lei YC, Tseng TC, Chen CL, Kao JH; C-TEAM study group and the Taiwan Liver Diseases Consortium. Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients. Liver Int. 2016;36:1755-1764. [PMID: 27634134 DOI: 10.1111/liv.13253] [Cited by in Crossref: 108] [Cited by in F6Publishing: 100] [Article Influence: 18.0] [Reference Citation Analysis]
142 Matsumoto N, Ogawa M, Kumagawa M, Watanabe Y, Hirayama M, Miura T, Nakagawara H, Matsuoka S, Moriyama M, Fujikawa H. Renal vein dilation predicts poor outcome in patients with refractory cirrhotic ascites: Renal vein and cirrhotic ascites. Hepatol Res 2018;48:E117-25. [DOI: 10.1111/hepr.12935] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
143 Cremers I, Ribeiro S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol. 2014;7:206-216. [PMID: 25177367 DOI: 10.1177/1756283x14538688] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
144 Qi X, He C, Yin Z, Wang Z, Zhang H, Yao L, Wang J, Xia J, Cai H, Yang Z, Bai M, Guo W, Niu J, Wu K, Fan D, Han G; PVT-TIPS Study Group. Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial. BMJ Open 2013;3:e003370. [PMID: 23847271 DOI: 10.1136/bmjopen-2013-003370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
145 Yang CH, Chiu YC, Chen CH, Chen CH, Tsai MC, Chuah SK, Lee CH, Hu TH, Hung CH. Diabetes mellitus is associated with gastroesophageal variceal bleeding in cirrhotic patients. Kaohsiung J Med Sci 2014;30:515-20. [PMID: 25438683 DOI: 10.1016/j.kjms.2014.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
146 Siddique O, Yoo ER, Perumpail RB, Perumpail BJ, Liu A, Cholankeril G, Ahmed A. The importance of a multidisciplinary approach to hepatocellular carcinoma. J Multidiscip Healthc. 2017;10:95-100. [PMID: 28360525 DOI: 10.2147/jmdh.s128629] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 4.4] [Reference Citation Analysis]
147 Qi X, Fan D, Han G. Timing of transjugular intrahepatic portosystmic for Budd-Chiari syndrome: still an open issue. Liver Int 2014;34:1288-9. [PMID: 24684318 DOI: 10.1111/liv.12554] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
148 Rahman WT, Hussain HK, Parikh ND, Davenport MS. Reinterpretation of Outside Hospital MRI Abdomen Examinations in Patients With Cirrhosis: Is the OPTN Mandate Necessary? American Journal of Roentgenology 2016;207:782-8. [DOI: 10.2214/ajr.16.16209] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
149 Hanafy AS, Basha MAK, Wadea FM. Novel markers of endothelial dysfunction in hepatitis C virus-related cirrhosis: More than a mere prediction of esophageal varices. World J Hepatol 2020; 12(10): 850-862 [PMID: 33200022 DOI: 10.4254/wjh.v12.i10.850] [Reference Citation Analysis]
150 Iwata K, Enomoto H, Nishiguchi S, Aizawa N, Sakai Y, Iwata Y, Tanaka H, Ikeda N, Takashima T, Saito M, Imanishi H, Iijima H, Tsuda Y, Higuchi K. Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis. J Clin Biochem Nutr 2014;55:147-52. [PMID: 25320463 DOI: 10.3164/jcbn.14-33] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
151 Teperman LW. Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes. Int J Hepatol 2013;2013:952828. [PMID: 24324895 DOI: 10.1155/2013/952828] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
152 Mullen K, Prakash R. Rifaximin for the treatment of hepatic encephalopathy. Expert Rev Gastroenterol Hepatol 2010;4:665-77. [PMID: 21108586 DOI: 10.1586/egh.10.78] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
153 Triantos CK, Tsintoni A, Karaivazoglou K, Grigoropoulou X, Tsolias C, Diamantopoulou G, Iconomou G, Thomopoulos K, Labropoulou-karatza C, Assimakopoulos K. Male hepatitis C patients’ sexual functioning and its determinants: . European Journal of Gastroenterology & Hepatology 2017;29:1241-6. [DOI: 10.1097/meg.0000000000000971] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
154 Sherman M, Bruix J, Porayko M, Tran T; AASLD Practice Guidelines Committee. Screening for hepatocellular carcinoma: the rationale for the American Association for the Study of Liver Diseases recommendations. Hepatology. 2012;56:793-796. [PMID: 22689409 DOI: 10.1002/hep.25869] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 10.4] [Reference Citation Analysis]